Athira Pharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athira Pharma and other ETFs, options, and stocks.

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018.

CEO

Mark J. Litton

CEOMark J. Litton

Employees

Employees35

Headquarters

Bothell, Washington

HeadquartersBothell, Washington

Founded

2011

Founded2011

Employees

Employees35

ATHA Key Statistics

Market cap

112.32M

Market cap112.32M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

255.94K

Average volume255.94K

High today

$3.16

High today$3.16

Low today

$2.95

Low today$2.95

Open price

$3.06

Open price$3.06

Volume

260.81K

Volume260.81K

52 Week high

$16.65

52 Week high$16.65

52 Week low

$2.53

52 Week low$2.53

Analyst ratings

67%

of 6 ratings

Buy

33.3%

Hold

66.7%

Sell

ATHA Earnings

-$0.65

-$0.43

-$0.22

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours